CLINICAL TRIALS PROFILE FOR CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

All Clinical Trials for CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00187655 ↗	Effect of, OAT3, on the Renal Secretion of Cefotaxime	Completed	University of California, San Francisco	Phase 1	2004-01-01	In the proposed study, we plan to use a genotype to phenotype strategy to study the role of the organic anion transporter, OAT3, in drug response. More specifically we will examine the contribution of OAT3 to the renal clearance of anionic drugs such as cefotaxime by studying individuals with a non-functional (or poorly-functional) variant of OAT3.
NCT02560207 ↗	Randomized Trial of Continuous Versus Intermittent Cefotaxime Infusion on ICU.	Completed	University Medical Center Groningen	Phase 4	2015-11-01	This study evaluates target attainment after either intermittent intravenous bolus or intravenous continuous infusion of cefotaxime in critically ill patients. Critically ill patients will be randomized to intermittent infusion or continuous infusion of cefotaxime.
NCT02959957 ↗	Disturbance of the Intestinal Microbiota by Temocillin vs Cefotaxime in Treatment of Febrile Urinary Tract Infections	Completed	Håkan Hanberger	Phase 4	2016-05-20	This study will evaluate the ecological impact on the intestinal microbiota and compare the safety and efficacy of temocillin compared to cefotaxime, in empiric treatment of febrile UTI. Half of participants will receive temocillin and the other half will receive cefotaxime.

Clinical Trial Conditions for CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Condition Name

Condition Name for CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Intervention	Trials
Critically Ill	1
Focus Groups	1
Urinary Tract Infections	1

Condition MeSH

Condition MeSH for CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Intervention	Trials
Communicable Diseases	1
Critical Illness	1
Urinary Tract Infections	1

Clinical Trial Locations for CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Trials by Country

Trials by Country for CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Location	Trials
Sweden	2
Netherlands	1

Clinical Trial Progress for CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Clinical Trial Phase

Clinical Trial Phase for CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Clinical Trial Phase	Trials
Phase 4	2
Phase 1	1

Clinical Trial Status

Clinical Trial Status for CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Clinical Trial Phase	Trials
Completed	3

Clinical Trial Sponsors for CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Sponsor Name

Sponsor Name for CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Sponsor	Trials
University of California, San Francisco	1
University Medical Center Groningen	1
Håkan Hanberger	1

Sponsor Type

Sponsor Type for CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Sponsor	Trials
Other	3